<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="144523">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01219244</url>
  </required_header>
  <id_info>
    <org_study_id>nutrition_memory_01</org_study_id>
    <nct_id>NCT01219244</nct_id>
  </id_info>
  <brief_title>Effects of Dietary Interventions on the Brain in Mild Cognitive Impairment (MCI)</brief_title>
  <official_title>Enhancing Memory Functions in Patients With Mild Cognitive Impairment by Dietary Interventions and in Combination With Exercise and Cognitive Training - Proof of Concept and Mechanisms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Federal Ministry of Education and Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will investigate whether dietary modification could provide positive effects on
      brain functions in elderly people with mild cognitive impairment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The age-related degradation of cognitive functions even to the point of neurodegenerative
      disorders such as Alzheimer`s disease are a growing public-health concern with devastating
      effects.

      Referring to animal data, empirical studies, and pilot human trials, dietary modification
      (caloric restriction, omega-3 fatty acids and resveratrol) should improve cognitive
      functions such as learning and memory. To test this hypothesis, the researchers study
      general brain functions in elderly subjects (50-80 years old) with mild cognitive
      impairment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Alzheimer's Disease Assessment Scale - cognitive subscale</measure>
    <time_frame>Prior to intervention and after 6 months of intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional/Structural brain changes</measure>
    <time_frame>Prior to intervention and after 6 months of intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma biomarkers</measure>
    <time_frame>Prior to intervention and after 6 months of intervention</time_frame>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">330</enrollment>
  <condition>Mild Cognitive Impairment</condition>
  <arm_group>
    <arm_group_label>Caloric restriction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>omega-3 supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>resveratrol supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2nd step: intervention + physical /cognitive training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>most effective dietary intervention plus physical and cognitive training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2nd step: most effective dietary intervention plus control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>most effective dietary intervention plus control</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>caloric restriction</intervention_name>
    <description>6 months of caloric restriction (15 %)</description>
    <arm_group_label>Caloric restriction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>omega-3 supplementation</intervention_name>
    <description>6 months of omega-3 supplementation</description>
    <arm_group_label>omega-3 supplementation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>resveratrol supplementation</intervention_name>
    <description>6 months of resveratrol supplementation</description>
    <arm_group_label>resveratrol supplementation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>6 months of placebo intake</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>2nd step: intervention + physical / cognitive training</intervention_name>
    <description>most effective dietary intervention plus physical and cognitive training</description>
    <arm_group_label>2nd step: intervention + physical /cognitive training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>2nd step: intervention + control</intervention_name>
    <description>most effective dietary intervention plus control</description>
    <arm_group_label>2nd step: most effective dietary intervention plus control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  subjects with mild cognitive impairment

          -  50-80 years old

          -  moderate to heavy weight (BMI 25-35)

        Exclusion Criteria:

          -  dementia

          -  diabetes

          -  severe disease

          -  younger than 50 years

          -  BMI &lt; 25
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Agnes Floeel, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Charité University Berlin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Neurology, Charité Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>December 21, 2016</lastchanged_date>
  <firstreceived_date>October 12, 2010</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Agnes Flöel</investigator_full_name>
    <investigator_title>Prof. Dr. med. Agnes Flöel, Neurologie</investigator_title>
  </responsible_party>
  <keyword>memory</keyword>
  <keyword>diet</keyword>
  <keyword>elderly</keyword>
  <keyword>cognition</keyword>
  <keyword>prevention</keyword>
  <keyword>lifestyle</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cognition Disorders</mesh_term>
    <mesh_term>Mild Cognitive Impairment</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Resveratrol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
